Sandra Philipp

6.3k total citations · 1 hit paper
79 papers, 3.5k citations indexed

About

Sandra Philipp is a scholar working on Immunology, Dermatology and Rheumatology. According to data from OpenAlex, Sandra Philipp has authored 79 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Immunology, 42 papers in Dermatology and 15 papers in Rheumatology. Recurrent topics in Sandra Philipp's work include Psoriasis: Treatment and Pathogenesis (53 papers), Dermatology and Skin Diseases (38 papers) and Autoimmune and Inflammatory Disorders Research (14 papers). Sandra Philipp is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (53 papers), Dermatology and Skin Diseases (38 papers) and Autoimmune and Inflammatory Disorders Research (14 papers). Sandra Philipp collaborates with scholars based in Germany, United States and Canada. Sandra Philipp's co-authors include Wolfram Sterry, Robert Sabat, Kerstin Wolk, Hans‐Dieter Volk, Kim Papp, Khusru Asadullah, Katrin Witte, Ellen Witte, Katarzyna Warszawska and Melinda Gooderham and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The Journal of Immunology.

In The Last Decade

Sandra Philipp

73 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis

2017 392 citations Alan Menter, Sandra Philipp et al. profile →

Peers

Countries citing papers authored by Sandra Philipp

Since Specialization

Citations

This map shows the geographic impact of Sandra Philipp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Philipp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Philipp more than expected).

Fields of papers citing papers by Sandra Philipp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Philipp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Philipp. The network helps show where Sandra Philipp may publish in the future.

Co-authorship network of co-authors of Sandra Philipp

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Philipp. A scholar is included among the top collaborators of Sandra Philipp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Philipp. Sandra Philipp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A comprehensive, tri‐national, cross‐sectional analysis of characteristics and impact of pruritus in psoriasis 2022 ·Journal of the European Academy of Dermatology and Venereology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sandra Philipp, Georgios Kokolakis, (unknown), Pavel Kolkhir, Dmitry Pogorelov, Karsten Weller, Martin Metz, Robert Sabat, Romuald Maleszka, Olga Yu. Olisova, Marcus Maurer, Tomasz Hawro	10
2	Prevalence and factors associated with sleep disturbance in adult patients with psoriasis 2022 ·Journal of the European Academy of Dermatology and Venereology ·(unknown), (unknown), Karsten Weller, Robert Sabat, Sandra Philipp, Georgios Kokolakis, (unknown), Martin Metz, Marcus Maurer, Tomasz Hawro	21
3	Drug survival and reasons for drug discontinuation in palmoplantar pustulosis: a retrospective multicenter study 2019 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Christian Kromer, Dagmar Wilsmann‐Theis, Sascha Gerdes, Sandra Philipp, Marthe‐Lisa Schaarschmidt, Astrid Schmieder, Mohammed Dakna, (unknown), Wiebke K. Peitsch, Rotraut Mößner	23
4	Maintenance of skin clearance with ixekizumab treatment of psoriasis: Three-year results from the UNCOVER-3 study 2018 ·Journal of the American Academy of Dermatology ·Craig L. Leonardi, Catherine Maari, Sandra Philipp, Orin M. Goldblum, Lu Zhang, Nicole Y. Burkhardt, Susan Ball, Lotus Mallbris, Pablo Gonzalez, Pablo Fernández‐Peñas, L. Puig	52
5	Systemische Therapien der Psoriasis und Psoriasisarthritis 2016 ·Der Hautarzt ·Sandra Philipp, Georgios Kokolakis, Robert Sabat	5
6	Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: Results of the randomized phase 3 CADMUS study 2015 ·Journal of the American Academy of Dermatology ·Ian Landells, Colleen Marano, (unknown), Shu Li, Yaowei Zhu, Lawrence F. Eichenfield, Peter H. Hoeger, Alan Menter, Amy S. Paller, Alain Taı̈eb, Sandra Philipp, Philippe Szapary, B. Randazzo	166
7	Systemic Antipsoriatic Combination Therapy with Fumaric Acid Esters for Plaque-Type Psoriasis: Report on 17 Cases 2015 ·Dermatology ·Dagmar Wilsmann‐Theis, Yvonne Frambach, Sandra Philipp, Ansgar Weyergraf, Arnd Jacobi, Rotraut Mößner, Sascha Gerdes	8
8	IL-19 Is a Component of the Pathogenetic IL-23/IL-17 Cascade in Psoriasis 2014 ·Journal of Investigative Dermatology ·Ellen Witte, Georgios Kokolakis, Katrin Witte, Sandra Philipp, Wolf‐Dietrich Doecke, Nina Babel, Bianca M. Wittig, Katarzyna Warszawska, (unknown), (unknown), Stefanie Kunz, Khusru Asadullah, Marshall E. Kadin, Hans‐Dieter Volk, Wolfram Sterry, Kerstin Wolk, Robert Sabat	136
9	IL-29 Is Produced by T _H 17 Cells and Mediates the Cutaneous Antiviral Competence in Psoriasis 2013 ·Science Translational Medicine ·Kerstin Wolk, Katrin Witte, Ellen Witte, Martin Raftery, Georgios Kokolakis, Sandra Philipp, Günther Schönrich, Katarzyna Warszawska, Stefan Kirsch, Susanna Prösch, Wolfram Sterry, Hans‐Dieter Volk, Robert Sabat	108
10	Recommendations for detection of individual risk for comorbidities in patients with psoriasis 2013 ·Archives of Dermatological Research ·Johannes Wohlrab, (unknown), Sascha Gerdes, Alexander Nast, Sandra Philipp, Marc Alexander Radtke, Diamant Thaçi, Wolfgang Köenig, Andreas Pfeiffer, Martin Härter, Michael P. Schön	36
11	Increased Prevalence of Metabolic Syndrome in Patients with Acne Inversa 2012 ·PLoS ONE ·Robert Sabat, (unknown), Sylke Schneider‐Burrus, (unknown), Georgios Kokolakis, (unknown), Sandra Philipp, (unknown), Kerstin Wolk, Wolfram Sterry	194
12	Safety and Efficacy of the Tumor Necrosis Factor Antagonists 2010 ·Seminars in Cutaneous Medicine and Surgery ·Frank Bachmann, Alexander Nast, Wolfram Sterry, Sandra Philipp	30
13	Expression of Tolerance Associated Gene-1, a Mitochondrial Protein Inhibiting T Cell Activation, Can Be Used to Predict Response to Immune Modulating Therapies 2009 ·The Journal of Immunology ·Kathrin Keeren, Markus Friedrich, (unknown), Sandra Philipp, Robert Sabat, Wolfram Sterry, Christine Brandt, Christian Meisel, Gerald Grütz, Hans‐Dieter Volk, Birgit Sawitzki	24
14	S3‐Leitlinie zur Therapie der Psoriasis vulgaris – Update: „Übersicht der Therapieoptionen” und „Efalizumab” 2009 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Alexander Nast, Matthias Augustin, Wolf‐Henning Boehncke, Joachim Klaus, Ulrich Mrowietz, H.M. Ockenfels, Sandra Philipp, Kristian Reich, Thomas Rosenbach, Martin Schlaeger, Michael Sebastian, Wolfram Sterry, Volker Streit, Peter Weisenseel, Berthold Rzany	5
15	IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-γ are not 2009 ·Journal of Molecular Medicine ·Kerstin Wolk, Harald S. Haugen, Wenfeng Xu, Ellen Witte, Kim Waggie, (unknown), Elmar vom Baur, Katrin Witte, Katarzyna Warszawska, Sandra Philipp, Caroline Johnson‐Léger, Hans‐Dieter Volk, Wolfram Sterry, Robert Sabat	348
16	The Th17 cytokine IL‐22 induces IL‐20 production in keratinocytes: A novel immunological cascade with potential relevance in psoriasis 2009 ·European Journal of Immunology ·Kerstin Wolk, Ellen Witte, Katarzyna Warszawska, Gundula Schulze‐Tanzil, Katrin Witte, Sandra Philipp, Stefanie Kunz, Wolf‐Dietrich Döcke, Khusru Asadullah, Hans‐Dieter Volk, Wolfram Sterry, Robert Sabat	144
17	Three decades of psoriasis research: where has it led us? 2007 ·Clinics in Dermatology ·Robert Sabat, Wolfram Sterry, Sandra Philipp, Kerstin Wolk	32
18	The evaluation of psoriasis therapy with biologics leads to a revision of the current view of the pathogenesis of this disorder 2006 ·Expert Opinion on Therapeutic Targets ·Sandra Philipp, Kerstin Wolk, (unknown), Elizabeth Wallace, (unknown), (unknown), Conny Höflich, Hans‐Dieter Volk, Wolfram Sterry, Robert Sabat	24
19	Pan-selectin antagonism improves psoriasis manifestation in mice and man 2005 ·Archives of Dermatological Research ·Markus Friedrich, Daniel Bock, Sandra Philipp, (unknown), Robert Sabat, Kerstin Wolk, (unknown), (unknown), Sewon Kang, Tomas Norman Dam, Rainer N. Zahlten, Wolfram Sterry, G. Wolff	51
20	Nausea and vomiting in fractionated radiotherapy: a prospective on-demand trial of tropisetron rescue for non-responders to metoclopramide. 1995 ·European Journal of Cancer Prevention ·Raymond Miralbell, Philippe Coucke, (unknown), (unknown), (unknown), Sandra Philipp, (unknown), (unknown), (unknown), Gunhild Hagen, (unknown), Sabine Bieri, Abdelkarim S. Allal, Sabine Balmer Majno, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact